Mirum Pharmaceuticals, Inc. (MIRM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.97B |
| Enterprise Value | 3.99B |
| P/E Ratio | -5.71 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 8.74 |
| Price/Book Ratio | -505.86 |
| Enterprise/Revenue | 9.44 |
| Enterprise/EBITDA | -7.51 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.39 |
| Operating Margin | -0.17 |
AD
Management Effectiveness
| Return On Assets | -0.82 |
| Return On Equity | -4.1 |
Income Statement
| Revenue | 521.31M |
| Revenue/Share | 9.75 |
| Gross Profit | 420.73M |
| EBITDA | 17.21M |
| Net Income | -23.36M |
| Diluted EPS | -0.47 |
Balance Sheet
| Total Cash | 438.29M |
| Total Cash/Share | 6.92 |
| Total Debt | 760.54M |
| Total Debt/Equity | -72.97 |
| Current Ratio | 2.86 |
| Book Value Per Share | -0.16 |
Price History
| 52-Week Change | 19.53 |
| 52-Week High | 130 |
| 52-Week Low | 63.23 |
| Moving Average 50 Days | 92.11 |
| Moving Average 200 Days | 98.61 |
Statistics
| Average Volume | 733,193 |
| Shares Outstanding | 64.93M |
| % Held by Institutions | 122.14 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
